Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in the Eurasian Economic Union (EAEU) has been steadily increasing in recent years, driven by various factors such as rising healthcare awareness, government initiatives, and the growing prevalence of infectious diseases.
Customer preferences: Customers in the EAEU region are increasingly seeking out vaccines that provide protection against a wide range of diseases. They are also looking for vaccines that are safe, effective, and affordable. In addition, customers are increasingly willing to pay for vaccines that offer long-term protection and are easy to administer.
Trends in the market: One of the key trends in the EAEU vaccines market is the growing demand for combination vaccines that provide protection against multiple diseases. This trend is being driven by the increasing prevalence of infectious diseases in the region, as well as the need for more efficient and cost-effective vaccination programs.Another trend in the EAEU vaccines market is the increasing focus on research and development of new vaccines. This trend is being driven by the need to develop vaccines that are effective against emerging infectious diseases, as well as the need to improve the safety and efficacy of existing vaccines.
Local special circumstances: The EAEU vaccines market is characterized by a high level of government involvement. Governments in the region are actively promoting vaccination programs and are investing heavily in the development of new vaccines. In addition, the EAEU region has a large population of young people, which is driving demand for vaccines that protect against childhood diseases.
Underlying macroeconomic factors: The EAEU vaccines market is being driven by a combination of factors, including rising healthcare awareness, increasing government investment in healthcare, and the growing prevalence of infectious diseases. In addition, the EAEU region has a large population of young people, which is driving demand for vaccines that protect against childhood diseases. Overall, the outlook for the EAEU vaccines market is positive, with strong growth expected in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
